Considering the functions of p16INK4A and cyclin D1 in G1 progression, as well as the role that p53 plays in mitotic check points, cell cycle regulation appears to be greatly disrupted in tumor cells of ESCC. The gene discussed is CDKN2A; the disease is neoplasm.